MedTrace Logo

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

NCT00904163 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2014-05-16

No results posted yet for this study

Summary

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited blistering disease caused by the absence of type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening RDEB subjects to determine additional characteristics of patients who survive to adulthood.

Conditions

  • Epidermolysis Bullosa Dystrophica

Sponsors & Collaborators

Principal Investigators

  • Alfred T Lane · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00904163 on ClinicalTrials.gov